Events/Photo Gallery

  • Home ›   Events/Photo Gallery ›   HC Amb Abhishek Singh visited Sam Pharmaceutical's facility in Lagos today, appreciating the 55-year legacy of this Indian-owned pharmaceutical company in Nigeria. With over 1,200 Nigerians employed, Sam Pharma exemplifies the strong India–Nigeria partnership in healthcare, job creation and industrial growth.

HC Amb Abhishek Singh visited Sam Pharmaceutical's facility in Lagos today, appreciating the 55-year legacy of this Indian-owned pharmaceutical company in Nigeria. With over 1,200 Nigerians employed, Sam Pharma exemplifies the strong India–Nigeria partnership in healthcare, job creation and industrial growth.

October 15, 2026

HC Amb Abhishek Singh visited Sam Pharmaceutical's facility in Lagos today, appreciating the 55-year legacy of this Indian-owned pharmaceutical company in Nigeria. With over 1,200 Nigerians employed, Sam Pharma exemplifies the strong India–Nigeria partnership in healthcare, job creation and industrial growth.
HC Amb Abhishek Singh visited Sam Pharmaceutical's facility in Lagos today, appreciating the 55-year legacy of this Indian-owned pharmaceutical company in Nigeria. With over 1,200 Nigerians employed, Sam Pharma exemplifies the strong India–Nigeria partnership in healthcare, job creation and industrial growth.
HC Amb Abhishek Singh visited Sam Pharmaceutical's facility in Lagos today, appreciating the 55-year legacy of this Indian-owned pharmaceutical company in Nigeria. With over 1,200 Nigerians employed, Sam Pharma exemplifies the strong India–Nigeria partnership in healthcare, job creation and industrial growth.
HC Amb Abhishek Singh visited Sam Pharmaceutical's facility in Lagos today, appreciating the 55-year legacy of this Indian-owned pharmaceutical company in Nigeria. With over 1,200 Nigerians employed, Sam Pharma exemplifies the strong India–Nigeria partnership in healthcare, job creation and industrial growth.

HC also welcomed the company's ambitious Phase II expansion, projected to deliver over three times the output of Phase I, further contributing to Nigeria's pharmaceutical manufacturing capacity and economic development.

Go to Navigation